Search Results - "Moots, P L"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET by Delbeke, D, Meyerowitz, C, Lapidus, R L, Maciunas, R J, Jennings, M T, Moots, P L, Kessler, R M

    Published in Radiology (01-04-1995)
    “…To determine the optimal cutoff level of fluorine-18-labeled fluorodeoxyglucose (FDG) uptake in the differentiation of low-grade from high-grade cerebral…”
    Get more information
    Journal Article
  2. 2

    On the Use of DSC-MRI for Measuring Vascular Permeability by Skinner, J T, Moots, P L, Ayers, G D, Quarles, C C

    Published in American journal of neuroradiology : AJNR (01-01-2016)
    “…Contrast agent extravasation has been shown to confound brain tumor perfusion measurements with DSC-MR imaging, necessitating the use of correction techniques…”
    Get full text
    Journal Article
  3. 3

    Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma by DOWELL, J. E, MOOTS, P. L, STEIN, R. S

    Published in Bone marrow transplantation (Basingstoke) (01-12-1999)
    “…A 31-year-old female with lymphoblastic lymphoma developed myasthenia gravis (MG) 26 months after receiving an allogeneic bone marrow transplant (BMT) from an…”
    Get full text
    Journal Article
  4. 4

    Transforming growth factor β as a potential tumor progression factor among hyperdiploid glioblastoma cultures : Evidence for the role of platelet-derived growth factor by JENNINGS, M. T, HART, C. E, COMMERS, P. A, WHITLOCK, J. A, MARTINCIC, D, MACIUNAS, R. J, MOOTS, P. L, SHEHAB, T. M

    Published in Journal of neuro-oncology (01-02-1997)
    “…Among early-passage, near-diploid gliomas in vitro, transforming growth factor type beta (TGF beta) has been previously shown to be an autocrine growth…”
    Get full text
    Conference Proceeding Journal Article
  5. 5

    The course of seizure disorders in patients with malignant gliomas by Moots, P L, Maciunas, R J, Eisert, D R, Parker, R A, Laporte, K, Abou-Khalil, B

    Published in Archives of neurology (Chicago) (01-07-1995)
    “…To describe the morbidity associated with seizures and the efficacy of anticonvulsant therapy in adult patients with malignant gliomas (MGs). A retrospective…”
    Get more information
    Journal Article
  6. 6

    Pitfalls in the management of patients with malignant gliomas by Moots, P L

    Published in Seminars in neurology (1998)
    “…Neurooncology requires the integration of the clinical history, physical examination, neuroimaging studies, neuropathology, surgery, radiation therapy, and…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Expression of transforming growth factor alpha in human gliomas by Schlegel, U, Moots, P L, Rosenblum, M K, Thaler, H T, Furneaux, H M

    Published in Oncogene (01-12-1990)
    “…Expression of transforming growth factor alpha (TGF alpha) is frequently associated with the development of human and animal tumors. Using a sensitive…”
    Get more information
    Journal Article
  9. 9

    Prolonged survival in carcinomatous meningitis associated with breast cancer by Moots, P L, Harrison, M B, Vandenberg, S R

    “…We describe a patient who survived for more than 7 years after the diagnosis of meningeal carcinomatosis associated with breast cancer. Meningeal…”
    Get more information
    Journal Article
  10. 10

    CLIN-PATHOLOGY by Alexandru, D., Satyadev, R., So, W., Lee, S. H., Lee, Y. S., Hong, Y.-K., Kang, C. S., Rodgers, S. D., Marascalchi, B. J., Strom, R. G., Riina, H., Samadani, U., Frempong-Boadu, A., Babu, R., Sen, C., Zagzag, D., Anderson, M. D., Abel, T. W., Moots, P. L., Odia, Y., Orr, B. A., Eberhart, C. G., Rodriguez, F., Sweis, R. T., Lavingia, J., Connelly, J., Cochran, E., van den Bent, M., Hartmann, C., Preusser, M., Strobel, T., Dubbink, H. J., Kros, J. M., von Deimling, A., Boisselier, B., Sanson, M., Halling, K. C., Diefes, K. L., Aldape, K., Giannini, C., Rodriguez, F. J., Ligon, A. H., Horkayne-Szakaly, I., Rushing, E. J., Ligon, K. L., Vena, N., Garcia, D. I., Douglas Cameron, J., Raghunathan, A., Wani, K., Armstrong, T. S., Vera-Bolanos, E., Fouladi, M., Gajjar, A., Goldman, S., Lehman, N. L., Metellus, P., Mikkelsen, T., Necesito-Reyes, M. J. T., Omuro, A., Packer, R. J., Partap, S., Pollack, I. F., Prados, M. D., Ian Robbins, H., Soffietti, R., Wu, J., Gilbert, M. R., Aldape, K. D., Prosniak, M., Harshyne, L. A., Andrews, D. W., Craig Hooper, D., Kagawa, N., Hosen, N., Kijima, N., Hirayama, R., Chiba, Y., Yamamoto, F., Kinoshita, M., Hashimoto, N., Fujimoto, Y., Yoshimine, T., Hu, J., Nuno, M., Patil, C., Rudnick, J., Phuphanich, S., Bannykh, S., Chu, R., Yu, J., Black, K., Choi, J., Kim, D., Shim, K. W., Kim, S. H., Kanno, H., Nishihara, H., Tanaka, S., Yanagi, T.

    Published in Neuro-oncology (Charlottesville, Va.) (01-10-2012)
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Molecular genetic analysis of a primitive neuroectodermal tumor arising after intracranial radiation and chemotherapy for leukemia by Johnson, Mahlon D, Moots, Paul L, Zhuang, Zhengping, Weil, Robert J

    “…Primitive neuroectodermal tumors are aggressive tumors of the central nervous system (CNS), yet their etiology remains unclear. We report a case of a primitive…”
    Get more information
    Journal Article
  15. 15

    Dural lesions mimicking meningiomas by Johnson, Mahlon D., Powell, Suzanne Z., Boyer, Philip J., Weil, Robert J., Moots, Paul L.

    Published in Human pathology (01-12-2002)
    “…Recently, a number of neoplastic and nonneoplastic entities have been reported that radiographically and clinically mimic meningiomas. Because these lesions…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy by Jennings, Mark T., Cmelak, Anthony, Johnson, Mahlon D., Moots, Paul L., Pais, Ray, Shyr, Yu

    Published in Pediatric Blood & Cancer (01-07-2004)
    “…Background These factors have been predictive for progressive disease on therapy (PDOT) among pediatric brain tumors: >1.5 cm2 unresectable tumor,…”
    Get full text
    Journal Article